Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel treatments for diseases in the areas of autoimmunity and cancer.
The company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, enables the high throughput profiling of
protein networks as a basis for improved validation, lead identification and speed in the development of innovative and effective therapeutics.
Merrimack is a privately-held company based in Cambridge, Massachusetts.
For additional information, please visit http://www.merrimackpharma.com.